Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Associated risk factors for hepatitis E seroprevalence among liver transplant recipients (CROSBI ID 704965)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Dinjar Kujundžić, Petra ; Đaković Rode, Oktavija ; Vince, Adriana ; Prpić, Jelena ; Jemeršić, Lorena ; Kolarić, Branko ; Ostojić, Ana ; Mrzljak, Anna Associated risk factors for hepatitis E seroprevalence among liver transplant recipients // Abstract Book. U: Journal of hepatology, 70(Suppl.1). 2019. str. e719-e720

Podaci o odgovornosti

Dinjar Kujundžić, Petra ; Đaković Rode, Oktavija ; Vince, Adriana ; Prpić, Jelena ; Jemeršić, Lorena ; Kolarić, Branko ; Ostojić, Ana ; Mrzljak, Anna

engleski

Associated risk factors for hepatitis E seroprevalence among liver transplant recipients

Background and aims: Hepatitis E virus (HEV) is an emerging disease in Europe, especially important among solid organ transplant (SOT) recipients who are at greater risk of developing acute and chronic graft hepatitis with progression to cirrhosis. It is proposed that foodborne transmission is the main route of HEV infection in developed countries. However, risk factors for the acquisition of HEV infection among SOT recipients are incompletely understood. This study aimed to determine exposure of HEV infection and associated socio-demographic risk factors. Background and aims: In this cross-sectional study, 242 Croatian SOT recipients were screened during routine post- transplant outpatient visits. All participants completed a risk factor assessment questionnaire. Blood samples were tested for anti-HEV IgG using an enzyme immune assay (Mikrogen, Germany) and nucleic acid extracts of whole blood were tested by an in- house real-time reverse-transcriptase polymerase chain reaction assay for HEV RNA. Results: Anti-HEV IgG seroprevalence in Croatian SOT recipients was 24.38%. No SOT patients had HEV viraemia at time of testing. The median time after transplant was 5 years (range 19 years). The majority of the recipients were male (69.0%) and major indication for SOTwas alcoholic liver disease (50.4%). Older age (OR = 1.05 ; 95%CI = 1.02-1.09), female gender (OR = 2.61 ; 95%CI = 1.42-4.81), rural area of residence (AOR = 2.17 ; 95%CI = 1.10-4.27), and specific factors within a household: a farm (AOR = 2.79 ; 95% CI = 1.31- 5.92), a water-well (AOR = 3.09 ; 95%CI = 1.11- 8.57) and a sewage system connected to a septic tank (AOR = 3.38 ; 95%CI = 1.64-6.95) were detected as potential risk factors, while highest level of education (AOR = 0.05 ; 95%CI = 0.01- 0.43) and a recent travelling experience (AOR = 0.39 ; 95%CI = 0.17-0.88) as protective factors. Contrary to initial assumptions, production and/or consummation of cured meat and occupational exposure had no statistically significant strength of association with anti-HEV IgG seropositivity. Conclusion: Prevalence of anti-HEV IgG in SOT recipients in Croatia is 24.38%. Identified socio- demographic factors associated with the seropositivity set up a platform for further research directions to evaluate sources/routes of transmission and clinical impact of HEV infection after SOT.

Hepatitis E virus ; Croatia ; liver ; transplantation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

e719-e720.

2019.

objavljeno

Podaci o matičnoj publikaciji

Abstract Book. U: Journal of hepatology, 70(Suppl.1)

Podaci o skupu

The International Liver Congress 2019

poster

10.04.2019-14.04.2019

Beč, Austrija

Povezanost rada

Kliničke medicinske znanosti, Temeljne medicinske znanosti